University of Virginia Brain Institute and School of Medicine researchers have received an initial $9.3 million award from the National Institutes of Health for a $30 million clinical trial to ...

Researchers at the University of Virginia Brain Institute and UVA School of Medicine will conduct a trial to see if the powerful anesthetic ketamine can save patients from prolonged, life-threatening ...

The University of Virginia (UVA) is spearheading a nationwide clinical trial exploring a new treatment option for prolonged ...

Investorideas , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Life Sciences and AI sectors ...

Neuraxpharm introduced Midazolam buccal as an anti-epileptic drug meant to treat status epilepticus. The buccal mucosal delivery of Midazolam provides a convenient and fast-absorbing method for ...

SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the ...

Patna: International Epilepsy Day, observed on the second Monday of Feb since 2015, aims to educate the public, break the ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to ...

Viehbacher, "Biogen") announced today that the U.S. Food and Drug Administration (FDA ... including seizure and status epilepticus, can occur. ARIA can be fatal. Serious intracerebral hemorrhages (ICH ...